4//SEC Filing
Gao Hanlin 4
Accession 0001193125-25-253873
CIK 0001674930other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 5:20 PM ET
Size
5.0 KB
Accession
0001193125-25-253873
Insider Transaction Report
Form 4
Gao Hanlin
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-10-26$23.74/sh−1,642$38,981→ 955,443 total
Footnotes (1)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001684532
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 5:20 PM ET
- Size
- 5.0 KB